Table 3.
|
Total | P | BCLC C | P | ||
---|---|---|---|---|---|---|
TACE-L (n = 51) |
TACE (n = 51) |
TACE-L (n = 36) |
TACE (n = 35) |
|||
Median OS (months) | 12.17 | 10.17 | .042 | 11.5 | 8.03 | .009 |
Median PFS (months) | 3.33 | 2.9 | .007 | 3.1 | 2.9 | .012 |
OS, overall survival; PFS, progression-free survival; TACE, transarterial chemoembolization.